IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler (RO) Disease: A Retrospective Analysis of French Cohort Data From 2009 to 2024
Clinical trial NCT07772050 · COMPLETED
Trial details
- NCT number
- NCT07772050
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-01-01
- Primary completion
- 2024-12-31
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.